SCHEMBL2459187

SCHEMBL2459187

Nc1ccccc1Nc1ccccc1-c1ccccc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 5/20 0.58
▸ HSD17B10 Q99714 2/20 0.58
▸ MAPT P10636 6/20 0.57
▸ KDM4E B2RXH2 5/20 0.57
▸ GAA P10253 5/20 0.57
▸ LMNA P02545 3/20 0.57
▸ MEN1 O00255 3/20 0.57
▸ KMT2A Q03164 3/20 0.57
▸ CYP1A2 P05177 1/20 0.57
▸ CYP2D6 P10635 1/20 0.57
▸ CYP2C9 P11712 1/20 0.57
▸ CYP2C19 P33261 1/20 0.57
▸ FABP3 P05413 1/20 0.55
▸ FABP4 P15090 1/20 0.55
▸ FABP5 Q01469 1/20 0.55
▸ MAPK13 O15264 2/20 0.53
▸ MAPK12 P53778 2/20 0.53
▸ MAPK11 Q15759 2/20 0.53
▸ MAPK14 Q16539 2/20 0.53
▸ SMN1; SMN2 Q16637 2/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2437912 0.87 FABP3 (0.67) ALDH1A1HSD17B10MAPTLMNAMEN1
SCHEMBL29574036 0.87 FABP3 (0.67) ALDH1A1HSD17B10MAPTLMNAMEN1
SCHEMBL15605284 0.84 FABP3 (0.64) ALDH1A1HSD17B10MAPTLMNAMEN1
SCHEMBL25565245 0.84 ALDH1A1 (0.54) ALDH1A1HSD17B10MAPTKDM4EGAA
Hydrochloric Acid SCHEMBL20916299 0.84 ALDH1A1 (0.54) ALDH1A1HSD17B10MAPTKDM4EGAA
Hydrochloric Acid SCHEMBL30515278 0.84 ALDH1A1 (0.54) ALDH1A1HSD17B10MAPTKDM4EGAA
SCHEMBL19752769 0.83 ALDH1A1 (0.48) ALDH1A1HSD17B10MAPTKDM4EGAA
SCHEMBL26547946 0.83 MAPT (0.48) ALDH1A1HSD17B10MAPTKDM4EGAA
SCHEMBL16616585 0.82 FABP3 (0.62) ALDH1A1HSD17B10LMNAMEN1KMT2A
SCHEMBL5370631 0.82 FABP3 (0.62) ALDH1A1HSD17B10LMNAMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4092274-A FROM AN ORTHO-SUBSTITUTED AROMATIC DICARBOXYLIC ACID ANHYDRIDE AND TETRACARBOXYLIC ACID DIANHYDRIDE WITH A CARBOCYCLIC TETRAAMINE NASA 1978-05-30 — — US claimed
US-11174258-B2 Benzimidazolo[1,2-a]benzimidazole derivatives for organic light emitting diodes IDEMITSU KOSAN CO., LTD. (JP) 2021-11-16 — — US disclosed
US-11174258-B2 Benzimidazolo[1,2-a]benzimidazole derivatives for organic light emitting diodes IDEMITSU KOSAN CO., LTD. (JP) 2021-11-16 — — US disclosed
US-20190002469-A1 BENZIMIDAZOLO[1,2-A]BENZIMIDAZOLE DERIVATIVES FOR ORGANIC LIGHT EMITTING DIODES IDEMITSU KOSAN CO., LTD. (JP) 2019-01-03 — — US disclosed
US-20190002469-A1 BENZIMIDAZOLO[1,2-A]BENZIMIDAZOLE DERIVATIVES FOR ORGANIC LIGHT EMITTING DIODES IDEMITSU KOSAN CO., LTD. (JP) 2019-01-03 — — US disclosed
EP-2362889-B1 PHOSPHORESCENT EMITTERS UNIVERSAL DISPLAY CORP (US) 2018-12-26 — — EP disclosed
WO-2017093958-A1 BENZIMIDAZOLO[1,2-A]BENZIMIDAZOLE DERIVATIVES FOR ORGANIC LIGHT EMITTING DIODES IDEMITSU KOSAN CO., LTD. (JP) 2017-06-08 — — WO disclosed
WO-2017093958-A1 BENZIMIDAZOLO[1,2-A]BENZIMIDAZOLE DERIVATIVES FOR ORGANIC LIGHT EMITTING DIODES IDEMITSU KOSAN CO., LTD. (JP) 2017-06-08 — — WO disclosed
EP-2957566-A1 ORGANIC LIGHT EMITTING DEVICE, HETEROLEPTIC IRIDIUM COMPLEXES AND METHOD OF PRODUCING 2-PHENYL BENZIMIDAZOLE DERIVATIVES Universal Display Corporation (US) 2015-12-23 — — EP disclosed
EP-2710020-B1 PHOSPHORESCENT HETEROLEPTIC PHENYLBENZIMIDAZOLE DOPANTS AND NEW SYNTHETIC METHODOLOGY UNIVERSAL DISPLAY CORP (US) 2015-06-24 — — EP disclosed
US-8367223-B2 Heteroleptic phosphorescent emitters UNIVERSAL DISPLAY CORPORATION (US) 2013-02-05 — — US disclosed
US-20120292601-A1 PHOSPHORESCENT HETEROLEPTIC PHENYLBENZIMIDAZOLE DOPANTS AND NEW SYNTHETIC METHODOLOGY UNIVERSAL DISPLAY CORPORATION (US) 2012-11-22 — — US disclosed
WO-2012158851-A1 PHOSPHORESCENT HETEROLEPTIC PHENYLBENZIMIDAZOLE DOPANTS AND NEW SYNTHETIC METHODOLOGY UNIVERSAL DISPLAY CORPORATION (US) 2012-11-22 — — WO disclosed
EP-2362889-A1 PHOSPHORESCENT EMITTERS Universal Display Corporation (US) 2011-09-07 — — EP disclosed
US-20100141127-A1 PHOSPHORESCENT EMITTERS UNIVERSAL DISPLAY CORPORATION (US) 2010-06-10 — — US disclosed
US-20100141127-A1 PHOSPHORESCENT EMITTERS UNIVERSAL DISPLAY CORPORATION (US) 2010-06-10 — — US disclosed
US-20100141127-A1 PHOSPHORESCENT EMITTERS UNIVERSAL DISPLAY CORPORATION (US) 2010-06-10 — — US disclosed
WO-2010056669-A1 PHOSPHORESCENT EMITTERS UNIVERSAL DISPLAY CORPORATION (US) 2010-05-20 — — WO disclosed
WO-2010056669-A1 PHOSPHORESCENT EMITTERS UNIVERSAL DISPLAY CORPORATION (US) 2010-05-20 — — WO disclosed
US-4154919-A CONDENSED FROM DIANHYDRIDE AND A TETRAAMINE, MINIMAL SOFTENING AND BURNING AT HIGH TEMPERATURE ACUREX CORPORATION (US) 1979-05-15 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100141127-A1 PHOSPHORESCENT EMITTERS PAICS, TYMP, NUDT1 ALDH1A1 695/4885HSD17B10 4746/4885MAPT 106/4885
US-11174258-B2 Benzimidazolo[1,2-a]benzimidazole derivatives for organic light emitting diodes KCNH2, KCNH3, KCNJ2 ALDH1A1 397/4885HSD17B10 4182/4885MAPT 2580/4885
US-20190002469-A1 BENZIMIDAZOLO[1,2-A]BENZIMIDAZOLE DERIVATIVES FOR ORGANIC LIGHT EMITTING DIODES KCNH2, KCNH3, KCNJ2 ALDH1A1 397/4885HSD17B10 4182/4885MAPT 2580/4885
US-20120292601-A1 PHOSPHORESCENT HETEROLEPTIC PHENYLBENZIMIDAZOLE DOPANTS AND NEW SYNTHETIC METHODOLOGY POF1B, OCIAD1, OCIAD2 ALDH1A1 4320/4885HSD17B10 3883/4885MAPT 567/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback